Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
The Biochemical Journal|November 10, 2018
GPCR structure and function relationship: identification of a biased apelin receptor mutantTing Ban, Xun Li, Xiaochuan Ma, et al.
Scientific Reports|June 26, 2021
MCM2-7 complex is a novel druggable target for neuroendocrine prostate cancerEn-Chi Hsu, Michelle Shen, Merve Aslan, et al.
Scientific Reports|April 8, 2021
Discovery of CASP8 as a potential biomarker for high-risk prostate cancer through a high-multiplex immunoassayShiqin Liu, Fernando Garcia-Marques, Chiyuan Amy Zhang, et al.
NPJ Breast Cancer|October 29, 2021
Oncogene-mediated metabolic gene signature predicts breast cancer outcomeMerve Aslan, En-Chi Hsu, Fernando J Garcia-Marques, et al.
British Journal of Cancer|October 5, 2023
ACAA2 is a novel molecular indicator for cancers with neuroendocrine phenotypeMichelle Shen, Shiqin Liu, Angus Toland, et al.
British Journal of Cancer|December 8, 2020
Discovery of PTN as a serum-based biomarker of pro-metastatic prostate cancerShiqin Liu, Michelle Shen, En-Chi Hsu, et al.
British Journal of Cancer|October 14, 2024
Identification of a 5-gene signature panel for the prediction of prostate cancer progressionMichelle Shen, Fernando García-Marqués, Arvind Muruganantham, et al.
Cancer Research|September 5, 2025
Extracellular Domain Shedding of TROP2 Activates EGFR Signaling to Drive Prostate Cancer MetastasisShiqin Liu, En-Chi Hsu, Merve Aslan, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 15, 2020
Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1En-Chi Hsu, Meghan A Rice, Abel Bermudez, et al.
Scientific Reports|January 4, 2024
High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarkerShiqin Liu, Sarah J Hawley, Christian A Kunder, et al.
Pageof 4